Forty-five patients with GC exhibited increased KPNA2 expression in cancer tissues (p < 0.0001, Fig. 9B), and 40 (63.5%) patients with GC exhibited KPNA2 mRNA levels that were at least twofold higher than those in the corresponding adjacent tissues (Fig. 9C). Here, KPNA2 is linked to gastric cancer.